Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Viruses | journal | 1.463 Q1 | 130 | 2542 | 3370 | 176776 | 19878 | 3311 | 5.88 | 69.54 | 46.57 |  |
| 2 | Frontiers in Cellular and Infection Microbiology | journal | 1.389 Q1 | 120 | 1394 | 1738 | 93905 | 10589 | 1697 | 6.00 | 67.36 | 45.98 | |
| 3 | Vaccines | journal | 1.004 Q2 | 85 | 1502 | 1076 | 91267 | 5345 | 1038 | 4.89 | 60.76 | 46.88 | |
| 4 | Tropical Medicine and Infectious Disease | journal | 0.924 Q2 | 38 | 210 | 454 | 10381 | 1770 | 446 | 3.80 | 49.43 | 42.57 | |
| 5 | Pathogens | journal | 0.901 Q2 | 70 | 1642 | 1468 | 108093 | 6702 | 1450 | 4.55 | 65.83 | 47.27 | |
| 6 | Current Tropical Medicine Reports | journal | 0.876 Q2 | 27 | 30 | 84 | 1695 | 320 | 84 | 5.33 | 56.50 | 51.06 | |
| 7 | Current Clinical Microbiology Reports | journal | 0.839 Q2 | 28 | 18 | 73 | 1464 | 280 | 73 | 2.88 | 81.33 | 75.51 | |
| 8 | Antibiotics | journal | 0.785 Q2 | 77 | 1553 | 1305 | 93008 | 6858 | 1277 | 5.08 | 59.89 | 47.93 | |
| 9 | Chemotherapy | journal | 0.742 Q2 | 61 | 39 | 98 | 1209 | 286 | 95 | 3.06 | 31.00 | 38.20 | |
| 10 | Experientia supplementum (2012) | journal | 0.433 | 11 | 19 | 54 | 2912 | 124 | 33 | 2.57 | 153.26 | 0.00 | |
| 11 | Intervirology | journal | 0.392 Q3 | 68 | 29 | 97 | 978 | 207 | 95 | 2.34 | 33.72 | 47.50 | |
| 12 | Infectious Disease Reports | journal | 0.385 Q3 | 26 | 97 | 84 | 3967 | 125 | 80 | 1.68 | 40.90 | 45.42 | |
| 13 | Frontiers in Allergy | journal | 13 | 83 | 3 | 6454 | 1 | 3 | 0.33 | 77.76 | 47.79 | | |
| 14 | Frontiers in Fungal Biology | journal | 11 | 72 | 7 | 5427 | 5 | 3 | 0.71 | 75.38 | 41.08 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data